Zydus Lifesciences Ltd.

Cadila Healthcare has reported results for the second quarter ended September 30, 2013.

The company has reported 81.57% rise in its net profit at Rs 151.76 crore for the quarter as compared to Rs 83.58 crore for the same quarter in the previous year. Total income of the company has increased by 10.72% at Rs 993.69 crore for quarter under review as compared to Rs  897.41 crore for the quarter ended September 30, 2012.

On the consolidated basis, the group has registered a growth of 93.75% in net profit after taxes, minority interest and share of profit / (loss) of associates  at Rs 183.37 crore as compared to Rs 94.64 crore in the same quarter previous year. Total income of the group rose 13.18% to Rs 1759.02 crore for quarter under review as against Rs 1554.10 crore in corresponding quarter previous year.